老年人维持性血液透析的死亡率和临床预测模型:一项针对 17,354 名亚洲患者的大型观察性队列研究

IF 4.3 3区 医学 Q1 UROLOGY & NEPHROLOGY
K. Noppakun, S. Nochaiwong, A. Tantraworasin, Jiraporn Khorana, P. Susantitaphong, A. Lumpaopong, S. Sritippayawan, V. Ophascharoensuk, C. Ruengorn
{"title":"老年人维持性血液透析的死亡率和临床预测模型:一项针对 17,354 名亚洲患者的大型观察性队列研究","authors":"K. Noppakun, S. Nochaiwong, A. Tantraworasin, Jiraporn Khorana, P. Susantitaphong, A. Lumpaopong, S. Sritippayawan, V. Ophascharoensuk, C. Ruengorn","doi":"10.1159/000535669","DOIUrl":null,"url":null,"abstract":"Background: Mortality following hemodialysis initiation may influence the decision to initiate hemodialysis in elderly patients. Our objective is to demonstrate mortality following hemodialysis initiation in elderly (≥70 years) and to derive a prediction risk score based on clinical and laboratory indicators to determine risk of all-cause mortality in patients aged ≥80 years.\nMethods: We identified elderly (≥70 years) who initiated maintenance hemodialysis between January 2005 and December 2016 using data from the Thai Renal Replacement Therapy Registry. The mortality rate was determined based on age categories. A predictive risk score for all-cause mortality was created for 4,451 patients aged ≥80 years by using demographics, laboratory values, and interview-based parameters. Using a flexible parametric survival analysis, we predicted mortality 3, 6 months, 1, 5, and 10 years after hemodialysis initiation.\nResults: 17,354 patients (≥70 years) were included, mean age 76.9±5.1 years, 46.5% male, and 6,309 (36.4%) died. Patient aged <80 years had a median survival time of 110.6 months. A 9-point risk score was developed to predict mortality in patients aged ≥80 years: age>85 years, male, body mass index<18.5 kg/m2, hemoglobin<10.0 g/dL, albumin<3.5 g/dL, substantial assistance required in daily living (1 point each), and Karnofsky Performance Score<50 (3 points). C-statistic of 0.797 indicated high model discrimination. Internal validation demonstrated good agreement between observed and anticipated mortality.\nConclusions: Hemodialysis is appropriate for patients aged 70–80 years. A risk score for mortality in patients aged ≥80 years has been developed. The score is based on seven readily obtainable and evaluable clinical characteristics.","PeriodicalId":7570,"journal":{"name":"American Journal of Nephrology","volume":"49 50","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mortality rates and a clinical predictive model for the elderly on maintenance hemodialysis: A large observational cohort study of 17,354 Asian patients\",\"authors\":\"K. Noppakun, S. Nochaiwong, A. Tantraworasin, Jiraporn Khorana, P. Susantitaphong, A. Lumpaopong, S. Sritippayawan, V. Ophascharoensuk, C. Ruengorn\",\"doi\":\"10.1159/000535669\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Mortality following hemodialysis initiation may influence the decision to initiate hemodialysis in elderly patients. Our objective is to demonstrate mortality following hemodialysis initiation in elderly (≥70 years) and to derive a prediction risk score based on clinical and laboratory indicators to determine risk of all-cause mortality in patients aged ≥80 years.\\nMethods: We identified elderly (≥70 years) who initiated maintenance hemodialysis between January 2005 and December 2016 using data from the Thai Renal Replacement Therapy Registry. The mortality rate was determined based on age categories. A predictive risk score for all-cause mortality was created for 4,451 patients aged ≥80 years by using demographics, laboratory values, and interview-based parameters. Using a flexible parametric survival analysis, we predicted mortality 3, 6 months, 1, 5, and 10 years after hemodialysis initiation.\\nResults: 17,354 patients (≥70 years) were included, mean age 76.9±5.1 years, 46.5% male, and 6,309 (36.4%) died. Patient aged <80 years had a median survival time of 110.6 months. A 9-point risk score was developed to predict mortality in patients aged ≥80 years: age>85 years, male, body mass index<18.5 kg/m2, hemoglobin<10.0 g/dL, albumin<3.5 g/dL, substantial assistance required in daily living (1 point each), and Karnofsky Performance Score<50 (3 points). C-statistic of 0.797 indicated high model discrimination. Internal validation demonstrated good agreement between observed and anticipated mortality.\\nConclusions: Hemodialysis is appropriate for patients aged 70–80 years. A risk score for mortality in patients aged ≥80 years has been developed. The score is based on seven readily obtainable and evaluable clinical characteristics.\",\"PeriodicalId\":7570,\"journal\":{\"name\":\"American Journal of Nephrology\",\"volume\":\"49 50\",\"pages\":\"\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2023-12-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Nephrology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000535669\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000535669","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:血液透析开始后的死亡率可能影响老年患者开始血液透析的决定。我们的目的是证明老年人(≥70岁)开始血液透析后的死亡率,并基于临床和实验室指标得出预测风险评分,以确定≥80岁患者的全因死亡率风险。方法:我们选取2005年1月至2016年12月期间开始维持性血液透析的老年人(≥70岁),使用泰国肾脏替代治疗登记处的数据。死亡率是根据年龄类别确定的。通过使用人口统计学、实验室值和基于访谈的参数,为4451名年龄≥80岁的患者创建了全因死亡率的预测风险评分。使用灵活的参数生存分析,我们预测了血液透析开始后3、6个月、1、5和10年的死亡率。结果:纳入患者17354例(≥70岁),平均年龄76.9±5.1岁,男性46.5%,死亡6309例(36.4%)。患者年龄85岁,男性,体重指数<18.5 kg/m2,血红蛋白<10.0 g/dL,白蛋白<3.5 g/dL,日常生活需要大量辅助(各1分),Karnofsky Performance Score<50(3分)。c统计量为0.797表示模型歧视程度高。内部验证表明观察到的死亡率和预期的死亡率之间有很好的一致性。结论:血液透析适合70 ~ 80岁患者。≥80岁患者的死亡率风险评分已经被开发出来。评分是基于七个容易获得和可评估的临床特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Mortality rates and a clinical predictive model for the elderly on maintenance hemodialysis: A large observational cohort study of 17,354 Asian patients
Background: Mortality following hemodialysis initiation may influence the decision to initiate hemodialysis in elderly patients. Our objective is to demonstrate mortality following hemodialysis initiation in elderly (≥70 years) and to derive a prediction risk score based on clinical and laboratory indicators to determine risk of all-cause mortality in patients aged ≥80 years. Methods: We identified elderly (≥70 years) who initiated maintenance hemodialysis between January 2005 and December 2016 using data from the Thai Renal Replacement Therapy Registry. The mortality rate was determined based on age categories. A predictive risk score for all-cause mortality was created for 4,451 patients aged ≥80 years by using demographics, laboratory values, and interview-based parameters. Using a flexible parametric survival analysis, we predicted mortality 3, 6 months, 1, 5, and 10 years after hemodialysis initiation. Results: 17,354 patients (≥70 years) were included, mean age 76.9±5.1 years, 46.5% male, and 6,309 (36.4%) died. Patient aged <80 years had a median survival time of 110.6 months. A 9-point risk score was developed to predict mortality in patients aged ≥80 years: age>85 years, male, body mass index<18.5 kg/m2, hemoglobin<10.0 g/dL, albumin<3.5 g/dL, substantial assistance required in daily living (1 point each), and Karnofsky Performance Score<50 (3 points). C-statistic of 0.797 indicated high model discrimination. Internal validation demonstrated good agreement between observed and anticipated mortality. Conclusions: Hemodialysis is appropriate for patients aged 70–80 years. A risk score for mortality in patients aged ≥80 years has been developed. The score is based on seven readily obtainable and evaluable clinical characteristics.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American Journal of Nephrology
American Journal of Nephrology 医学-泌尿学与肾脏学
CiteScore
7.50
自引率
2.40%
发文量
74
审稿时长
4-8 weeks
期刊介绍: The ''American Journal of Nephrology'' is a peer-reviewed journal that focuses on timely topics in both basic science and clinical research. Papers are divided into several sections, including:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信